Ivas Michael R.

VP Michael R. Ivas sells 120,000 APH shares at $140.05 for $16.8M, reducing holdings 44.1%

Michael R. Ivas, VP & Corporate Controller, sold 120,000 shares (120.0K shares) at $140.05 on 2025-11-05, reducing his position from 272,412 to 152,412 shares—a 44.1% reduction in holdings. The sale occurred near the 52-week high of $141.55 (-2.4% from peak), and at a transaction price $1.94 above the current price of $138.11. Across his cross-ticker trading history, Ivas's prior 3 sells returned an average of +24.8% over 90 days with a 0.00% well-timed rate, indicating those sales preceded subsequent gains rather than declines. At APH specifically, his 2 measurable prior sells (2025-08-08 and 2025-05-29) also showed positive 90-day returns of +25.5% and +24.0% respectively, with neither meeting the criterion for well-timed exit (0 of 2 prior sells had negative 90d outcomes). This pattern suggests that timing relative to subsequent price movement is not a distinguishing feature of his sales at this ticker.

VP & Corporate Controller Ivas sells 120.0K APH shares (44.1% reduction) for $17.0M at $141.30

Ivas Michael R., VP & Corporate Controller, executed a substantial open-market sale of 120,000 shares on 2025-10-31 at $141.30, reducing his post-transaction holdings from 272,412 to 152,412 shares—a 44.1% reduction. The transaction occurred near the 52-week high of $141.55, with the stock up 15.8% over the prior 30 days and 31.2% over 90 days. At APH specifically, his prior two trades (sells on 2025-08-08 and 2025-05-29) showed mixed outcomes: the May sale proved well-timed with a 90-day return of +24.0%, but the timing pattern across measurable APH outcomes is 0 of 1 well-timed at the 90-day mark. The company's fundamentals remain solid with $6.2B in latest quarterly revenue, net income of $1.2B, and annual revenue growth of 21.2%, though the P/E of 45.37 reflects elevated valuation expectations.

VP & Corporate Controller Michael R. Ivas sold 50,000 shares of APH at $110.02 on 2025-08-08, reducing holdings 24.7% to 152,412 shares.

Michael R. Ivas, VP & Corporate Controller, executed a single open-market sale of 50,000 shares for $5,500,820.00, reducing his position by 24.7% to 152,412 shares post-transaction. The transaction occurred at $110.02, just below the current price of $111.85 and near the 52-week high of $111.85. Amphenol is a large-cap company with strong recent momentum (30-day: +13.2%, 90-day: +30.6%) and solid fundamentals (revenue $5.7B, net income $1.1B, annual growth +21.2%). His cross-ticker track record shows 1 prior sell with a 30-day return of +10.0%, while his single prior APH transaction (a May 2025 sell) also posted a 30-day return of +10.0%. The transaction represents a material reduction in an executive's direct holdings but lacks evidence of broader institutional concern, as no prior sales at this ticker exhibit well-timed exits.

VP & Corporate Controller Ivas Michael R. sold 40,000 shares of APH at $88.79; maintains 152,412 shares post-transaction

Michael R. Ivas, VP & Corporate Controller of Amphenol, sold 40,000 shares on 2025-05-29 for $3,551,408.00, reducing his holdings from 192,412 to 152,412 shares—a net decrease of 20.8% versus pre-transaction holdings. The sale occurred near the 52-week high of $89.93, with the company's stock up 16.9% over 30 days and 35.0% over 90 days. Amphenol is a large-cap, profitable business trading at a P/E of 41.63 with strong fundamentals: $4.8B quarterly revenue, $737.8M net income, and 21.2% annual revenue growth. The transaction represents a notable reduction in a material insider position, though the executive retains substantial holdings, warranting investor attention to any broader context around capital allocation or insider confidence at current valuation levels.